Holen Sie sich die Stockscreener-App
125.00
1.22%
-3.0627
Schlusskurs vom Vortag:
$128.06
Offen:
$126.51
24-Stunden-Volumen:
213.46K
Relative Volume:
0.12
Marktkapitalisierung:
$8.24B
Einnahmen:
$409.48M
Nettoeinkommen (Verlust:
$-81.28M
KGV:
-94.08
EPS:
-1.3286
Netto-Cashflow:
$-95.14M
1W Leistung:
-3.44%
1M Leistung:
+9.36%
6M Leistung:
+161.74%
1J Leistung:
+404.18%
1-Tages-Spanne:
$125.04
$130.99
1-Wochen-Bereich:
$120.71
$133.95
52-Wochen-Spanne:
$23.30
$155.44
Twist Bioscience Corp Stock (TWST) Company Profile
Firmenname
Twist Bioscience Corp
Sektor
Branche
Telefon
800-719-0671
Adresse
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, NTRA, IQV, IDXX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
125.24 | 8.43B | 409.48M | -81.28M | -95.14M | -1.3286 |
TMO
Thermo Fisher Scientific Inc
|
603.14 | 222.97B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.91 | 144.27B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
324.61 | 46.72B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
256.62 | 42.67B | 16.63B | 1.39B | 2.12B | 8.0674 |
IDXX
Idexx Laboratories Inc
|
518.37 | 40.98B | 4.45B | 1.10B | 1.06B | 13.59 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-04 | Eingeleitet | Stephens | Overweight |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-06-04 | Eingeleitet | Guggenheim | Buy |
| 2024-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-27 | Eingeleitet | Berenberg | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-29 | Eingeleitet | William Blair | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Neutral |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-02-05 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2018-11-26 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference - Yahoo Finance
After $14M August sale, Twist Bioscience (NASDAQ: TWST) investor plans another stock sale - Stock Titan
Officer at Twist Bioscience (TWST) preps 907-share sale - Stock Titan
Twist Bioscience (NASDAQ: TWST) insider to sell shares, including stock to cover taxes - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer plans about $50K stock sale - Stock Titan
Cathie Wood’s ARK reveals stake in Twist Bioscience (NASDAQ: TWST) - Stock Titan
Claim your share of the $17 million Twist Bioscience securities class action settlement - claimdepot.com
An investor holds voting power over 8.8M Twist Bioscience (TWST) shares - Stock Titan
Twist Bioscience (TWST) Rallied as AI and Pharma Drive DNA Demand - Yahoo Finance
About Twist Bioscience Corporation • Robinhood Token - Coinbase
Cathie Wood’s ARK sees major stock moves with Robinhood and Twist Bioscience - Investing.com
Twist Bioscience Corp (TWST) Shares Fall 3.0% -- What GF Score o - GuruFocus
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 - Moomoo
Twist Bioscience Corp (TWST) Stock Down 5.0% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience Slides as Investors Appear to Cool on Recent AI-Fueled Rally - Quiver Quantitative
Twist Bioscience Corp (TWST) Key Financial Ratios – Valuation, Profitability & More - Value Research
Twist Bioscience (NASDAQ: TWST) insider sells millions in stock - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer sets 854-share sale tied to equity taxes - Stock Titan
Guggenheim reiterates Twist Bioscience stock rating on AI drug discovery potential - Investing.com
Twist Bioscience Executive Dennis Cho Sells 14,205 Shares Under 10b5-1 Plan in August 2026 - Kalkine Media
Twist Bioscience Stock Surges As Anthropic AI Deal And Upbeat Guidance Reset Outlook - StocksToTrade
Twist Bioscience (NASDAQ: TWST) seller plans more after $14.2M August stock trade - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer adds $189K sale after $2.1M June trade - Stock Titan
Twist Bioscience (NASDAQ: TWST) holder to sell 1,965 shares for taxes, compensation - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer booked $1.84M in one sale, now plans more stock trades - Stock Titan
Twist Bioscience (NASDAQ: TWST) insider to sell 669 shares - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer to sell 4,046 shares after $9.2M August sale - Stock Titan
Twist Bioscience Corp (TWST) Stock Down 4.3% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience (TWST) COO sells 78K shares under 10b5-1 plan - Stock Titan
Twist Bioscience stock hits 52-week high at 143.1 USD - Investing.com
Twist Bioscience (NASDAQ:TWST) Shares Gap DownHere's What Happened - MarketBeat
Twist Bioscience stock hits 52-week high at 143.1 USD By Investing.com - Investing.com Canada
Twist Bioscience benefits from Claude's advances in protein design - marketscreener.com
Twist Bioscience Registers 35,114 Shares for Resale by Invenra - Minichart
Twist Bioscience files prospectus supplement for Invenra share resale - Investing.com
Twist Bioscience (NASDAQ: TWST) clears path for 35K-share resale - Stock Titan
Twist Bioscience Stock Rallies As Guidance And Targets Jump - StocksToTrade
Twist Bioscience Stock Resilient Despite Scorpion Capital Short Report - Benzinga
Short seller Scorpion Capital bets against Twist Biosciences questioning AI partnership claims - Investing.com
Twist Bioscience Shares Rise After Selection by Anthropic to Evaluate Protein Design Project - marketscreener.com
Twist Bioscience (NASDAQ: TWST) officer may sell $1.84M in shares - Stock Titan
Twist Bioscience jumps as investors build on strong guidance and AI-drug-discovery enthusiasm - Quiver Quantitative
TWST Looks 163.5% Overvalued on GF Value™ - GuruFocus
Twist Bioscience Up Over 17%, on Track for Highest Close Since April 2021 -- Data Talk - Bitget
Why is Twist Bioscience stock surging today? By Investing.com - Investing.com Nigeria
Twist Bioscience (NASDAQ:TWST) Hits New 52-Week HighShould You Buy? - MarketBeat
Why is Twist Bioscience stock surging today? - Investing.com
Twist Bioscience Selected as Independent Evaluator in Anthropic's AI-Driven Protein Design Initiative - Kalkine Media
Form 8K Twist Bioscience Corp For: 19 August By Investing.com - Investing.com Nigeria
Twist Bioscience selected as evaluator for Anthropic AI protein design project - Investing.com
Anthropic selects Twist Bioscience as independent evaluator for AI-designed protein testing - TradingView
Finanzdaten der Twist Bioscience Corp-Aktie (TWST)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.07%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):